Salute e Benessere

Interleukin-13 Inhibitors Market Predicted to Surge During the Forecast Period…

Key Takeaways from the Interleukin-13 Inhibitors Market Report Key Takeaways from the Interleukin-13 Inhibitors Market Report Discover which indication is expected to grab the major interleukin-13 inhibitors market share @Interleukin-13 Inhibitors Market Report Key Factors Driving the Interleukin-13 Inhibitors Market Domination of DUPIXENT in the IL-13 market DUPIXENT (dupilumab), a blockbuster biologic developed by Sanofi and Regeneron, currently dominates the market...
PR Newswire
17/09/2025

Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6%…

Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy ® ) achieved significant weight loss, with one in three study participants losing 20% or more body weight 1** Oral semaglutide 25 mg also demonstrated improvements in the ability to perform everyday physical activities such as bending, standing, walking, being physically active, and improvements in cardiovascular risk factors 1 Oral semaglutide 25 mg is the first oral GLP-1 therapy submitted to the US Food and Drug...
Nasdaq GlobeNewswire
17/09/2025

Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the…

Postpartum depression is a leading cause of maternal mortality in Europe 1-2, and is one of the most common medical conditions associated with pregnancy 3-5 ; up to 20% of women experience postpartum depressive symptoms 6-11 The approval of this new therapeutic approach introduces an oral, 14-day treatment specifically indicated for PPDThe EC approval of ZURZUVAE is based on the SKYLARK study, which demonstrated rapid relief from depressive symptoms as early as day 3 and sustained...
Nasdaq GlobeNewswire
17/09/2025

SAM Medical expands emergency medical offering with strategic acquisition of…

"The acquisition of TyTek Medical strengthens our ability to deliver a comprehensive range of solutions for emergency medical professionals," said Jim Seidel, CEO of SAM Medical. "TyTek's strong reputation for high-quality, life-saving products aligns perfectly with our commitment to support first responders in their most critical moments. This acquisition better positions us to set the standard in the markets we serve." "The acquisition of TyTek Medical strengthens our…
PR Newswire
17/09/2025

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900…

Data show a favorable safety profile and early efficacy signals in a heavily pre-treated population whose cancer progressed after multiple prior lines of therapy including anti-PD-1Recommended phase 2 dose (RP2D) established at 33% of gross tumor volume (GTV)47.4% (9/19) best observed objective response rate (ORR) in all lesions per RECIST 1.178.9% (15/19) best observed disease control rate (DCR) in all lesions per RECIST 1.114.6 months median Overall Survival (mOS) in all patients...
Nasdaq GlobeNewswire
17/09/2025

Are Women on the Frontline of Antimicrobial Resistance?

National Patient Survey of Women’s Urinary Tract Infection (UTI) and Prenatal Screening reveals women suffering from UTI concerned about immediate antibiotic prescribing and Antimicrobial Resistance (AMR), especially during pregnancy.The survey was commissioned by Forte Medical, the UK based SME working to revolutionise diagnosis and treatment for Urinary Tract Infection and prenatal screening.Key survey results92% of respondents reported urine spillage onto hands, clothes, toilet...
Nasdaq GlobeNewswire
17/09/2025

Digital Health Market Is Projected to Reach US$ 1921.38 Billion By 2031 With…

The report from The Insight Partners, therefore, provides several stakeholders—including digital forensics solution providers, law enforcement & government agencies, cybersecurity firms, regulatory & standards organizations, and end-users—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. The report from The Insight Partners, therefore, provides several stakeholders—including digital forensics solution providers, law…
PR Newswire
17/09/2025

Diabetes Care Devices Market worth US$61.2 billion by 2030 with 12.3% CAGR |…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375 Browse in-depth TOC on "Diabetes Care Devices Market" 200 - Tables 60 - Figures 250 - Pages By product type,the global diabetes care devices market is divided into three main segments: blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. The blood glucose...
PR Newswire
17/09/2025

Clinical Microbiology Market worth US$7.34 billion by 2030 with 6.6% CAGR |…

Browse in-depth TOC on "Clinical Microbiology Market" Browse in-depth TOC on "Clinical Microbiology Market" 470 - Tables 53 - Figures 410 - Pages By end user,the clinical microbiology market is segmented into hospitals & diagnostic centers, contract testing laboratories, and academic & research institutes. In 2024, the diagnostic centers segment accounted for the largest market share, primarily due to the high patient volume, increasing incidence of infectious...
PR Newswire
17/09/2025

Notice of Annual General Meeting 2025

ANNOUNCEMENT NO. 293 17 September 2025Notice of Annual General Meeting Notice is hereby given of the Annual General Meeting, which will be held on Thursday 9 October 2025 at 5.30 p.m.The general meeting will be held at Nordsjællands KonferenceCenter, Gydevang 39-41, 3450 AllerødAdditional info Kim Nicolajsen, CFOTelefon (+45) 48 13 10 20About ChemoMetec A/SChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of...
Nasdaq GlobeNewswire
17/09/2025

Esaote opens new offices in Maastricht and reaffirms its presence in the…

In the Netherlands, Esaote intends to continue its growth by developing innovative solutions both in the sector of ultrasound as well as of Medical IT (in particular software solutions developed for interventional cardiologists and cardiac surgeons i.e. cardiac structural imaging, endovascular analysis, pre-operative sizing and planning). Inthe Netherlands , Esaote intends to continue itsgrowth by developing innovative solutions both in the sector of ultrasound as well as of Medical IT...
PR Newswire
17/09/2025

Advancing Cancer Research Brings New Hope for Patients Worldwide

Click here to view the custom infographic of the Oncotelic Therapeutics editorial. Clickhere to view the custom infographic of the Oncotelic Therapeutics editorial. The Pressing Demand for New Therapies Despite decades of research and billions in spending, some of the most aggressive cancers remain devastatingly lethal. Glioblastoma, the most frequently diagnosed malignant brain tumor in adults, still carries amedian survival of only about 15 months, even with surgery,...
PR Newswire
17/09/2025

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from…

SKY-0515's Phase 2/3 FALCON-HD trial in patients in Australia and New Zealand is ongoing SKY-0515's Phase 2/3 FALCON-HD trial in patients inAustraliaandNew Zealandis ongoing BOSTON , Sept. 17, 2025 /PRNewswire/ --Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today announced positive results from the first interim analysis of the Part C patient cohort in its Phase 1...
PR Newswire
17/09/2025

Insightec's Incisionless Focused Ultrasound Therapy Successfully Treats Downton…

ET is a debilitating and progressive neurological movement disorder that causes involuntary shaking, commonly of the hands and arms, but it can also affect the head, voice, and other parts of the body.3 The condition can significantly impact daily activities and quality of life, including the ability to work, with over 40% saying it impacts their ability to socialise and continue hobbies.4 ET is a debilitating and progressive neurological movement disorder that causes involuntary shaking,...
PR Newswire
17/09/2025

Amphista Therapeutics discloses first details of its SMARCA2 degrader program

Structurally-guided discovery using high-resolution cryo-EM has delivered potent, DCAF16-dependent Targeted Glues™ of SMARCA2, with exquisite selectivity over close homolog, SMARCA4.Rapid, deep and sustained degradation of SMARCA2 has been achieved, with a wide margin over SMARCA4. CNS penetrant SMARCA2 Targeted Glues™ have been identified within the program, offering the potential for differentiation to all other agents on this critical parameter. Cambridge, UK, 17 September 2025...
Nasdaq GlobeNewswire
17/09/2025

AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to…

ACUT ), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, today announced an expansion of its blood-based testing capabilities in partnership with EmeritusDX, a rapidly growing cancer diagnostics and information company. The two companies are building out their best-in-class product portfolios and respective infrastructures to meet growing clinical demand for non-invasive testing technologies.A key milestone in this expansion is the...
Nasdaq GlobeNewswire
17/09/2025

Material Testing Market worth $1,070.9 million by 2030 - Exclusive Report by…

269 - Tables49 - Figures249 - Pages 269 - Tables 49 - Figures 249 - Pages Download PDF Brochure :https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=207231755 The market for material testing is primarily driven by the growing demand for quality assurance and regulatory compliance across various industries to ensure the safety and reliability of materials. Additionally, there is a significant expansion in the demand for contracted material testing services, fueled by growth...
PR Newswire
17/09/2025

Rudholm Group Celebrates 35 Years of Global Growth Since Wollin's Visionary…

Wigan's unparalleled talent has earned him international acclaim. His works have been commissioned by Queen Elizabeth II, King Charles III, and other global icons. Each sculpture, crafted under a microscope with tools as fine as eyelashes, reflects precision, patience, and mastery, qualities that mirror the Rudholm philosophy. Wigan's unparalleled talent has earned him international acclaim. His works have been commissioned byQueen Elizabeth II,King Charles III, and other global icons...
PR Newswire
17/09/2025

China's Exporter Adapts to New Economic Realities as Canton Fair Highlights…

Moreover, Chinese technology-intensive and high-value products have won broader recognition in developed and emerging markets alike. At the 137th Canton Fair, a Rwandan buyer, facing Africa's digital shift, sealed a deal for LED/LCD displays to introduce smart solutions locally. A Pakistani buyer, noting the soaring demand for energy-saving appliances in his country, called the fair his top source for cost-effective, quality Chinese goods. These evolving demands are prompting Chinese companies…
PR Newswire
17/09/2025

Amber Implants Secures FDA 510(k) Clearance for VCFix® Spinal System: A…

One-year follow-up data from initial clinical trials of the VCFix® Spinal System, announced in June 2025, demonstrated immediate and sustained reduction in pain, improved spinal stability, and faster recovery, underscoring its potential for lasting functional benefits. Amber Implants is also working towards CE marking in the EU, aiming for broad labeling that supports both stand-alone use of VCFix®, and integration with posterior fixation systems. One-year follow-up data from initial clinical...
PR Newswire
17/09/2025

ENGWE Opens First Pop-Up Store in Germany: Accelerating European Market…

Looking ahead to 2026, ENGWE will expand its physical footprint across Germany, opening dedicated brand stores in Berlin, Munich, Frankfurt, Bochum, and Cologne, aiming to reach roughly five million riders. The company will keep showing up at Eurobike and execute a "Product + Channel + Ecosystem" strategy that pairs compelling products with accessible retail and community services to speed adoption across Europe's largest single market. Looking ahead to 2026, ENGWE will expand…
PR Newswire
17/09/2025

Implantica's RefluxStop® sparks strong excitement at the American Foregut…

As the third and final module of the PMA application nears completion, we see a massive wave of interest emerging from surgeons in the US and worldwide, also witnessed at AFS. Accordingly, Implantica has started to build the necessary infrastructure, inventory, resources, and launch teams to deliver a speedy US rollout upon the PMA approval. As the third and final module of the PMA application nears completion, we see a massive wave of interest emerging from surgeons in the US and worldwide,...
PR Newswire
17/09/2025

Press Release: EADV: Sanofi’s brivekimig achieved positive results in…

EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a studyIn phase 2a study, brivekimig led to clinically meaningful improvements in primary and key secondary endpoints in biologic-naïve patients compared to placebo at week 16Dual-target Nanobody® VHH inhibiting TNF and OX40L being explored across a range of immune-mediated diseasesReaffirms Sanofi’s commitment to addressing underlying inflammation across complex, heterogeneous chronic skin...
Nasdaq GlobeNewswire
17/09/2025

Malaysia Healthcare Week Debuts in Kuwait, Strengthening Malaysia-Kuwait Medical…

Malaysia Healthcare Week in Kuwait provides a platform to strengthen Malaysia–Kuwait bilateral healthcare collaboration while showcasing Malaysia's position as a regional healthcare leader. By highlighting Malaysia's world-class medical expertise and advanced healthcare infrastructure, the event reinforces the country's reputation for delivering exceptional patient care and supports greater collaboration in medical training and knowledge exchange. The initiative positions Malaysia as the trusted…
PR Newswire
17/09/2025
Altri  Comunicati